Search results
Results From The WOW.Com Content Network
The Workplace Safety and Insurance Board (WSIB) is the workplace compensation board for provincially regulated workplaces in Ontario.As an agency of the Ontario government, the WSIB operates "at arm's length" from the Ministry of Labour, Training and Skills Development and is solely funded by employer premiums, administration fees, and investment revenue.
Shipment Status Inquiry (Ocean) 315 Status Details (Ocean) 317 Delivery/Pickup Order 319 Terminal Information 322 Terminal Operations and Intermodal Ramp Activity 323 Vessel Schedule and Itinerary (Ocean) 324 Vessel Stow Plan (Ocean) 325 Consolidation of Goods In Container 326 Consignment Summary List 350 Customs Status Information 352
The WSIAT was formerly known as the Workers' Compensation Appeals Tribunal (WCAT) which was established Oct 1, 1985 by the Ontario government. [2] In 1998, the Workplace Safety and Insurance Act came into force and changed the name of the Tribunal to Workplace Safety and Insurance Appeals Tribunal.
However, such appeals are difficult and are regarded skeptically by most state appellate courts, because the point of workers' compensation was to reduce litigation. A few states still allow the employee to initiate a lawsuit in a trial court against the employer. For example, Ohio allows appeals to go before a jury. [54]
In United States pharmaceutical regulatory practice, a Complete Response Letter (CRL), or more rarely, a 314.110 letter, is a regulatory action by the Food and Drug Administration in response to a New Drug Application, Amended New Drug Application or Biologics License Application, indicating that the application will not be approved in its present form. [1]
A query letter is a formal letter sent by a writer to magazine editors, literary agents and sometimes publishing houses or companies, to propose writing ideas. [1]For example, a standard requested format for a manuscript query letter to a literary agent could be approximately 200–400 words, expressing the following information:
The United States Food and Drug Administration's Investigational New Drug (IND) program is the means by which a pharmaceutical company obtains permission to start human clinical trials and to ship an experimental drug across state lines (usually to clinical investigators) before a marketing application for the drug has been approved.
Although form letters are generally intended for a wide audience, many form letters include stylistic elements or features intended to appear specifically tailored to the recipient. For example, they might be signed by autopen and use features such as mail merge, which automatically inserts the names of the individual recipients.